BTAIQ — BioXcel Therapeutics Share News
0.000.00%
Last trade - 00:00- $0.53m
- $92.14m
- $0.64m
BioXcel Therapeutics Inc reports results for the quarter ended in January - Earnings Summary
Brief: BioXcel Therapeutics Q1 Basic EPS USD -0.87 Vs. IBES Estimate USD -0.7
BioXcel Therapeutics Inc expected to post a loss of 70 cents a share - Earnings Preview
Brief: BioXcel Therapeutics Announces TRANQUILITY In-Care Pivotal Phase 3 Trial Plan With BXCL501
Brief: BioXcel Therapeutics Announces $25 Million Registered Direct Offering
U.S. STOCKS ON THE MOVE-Rumble, Geron, Gold miners
U.S. STOCKS ON THE MOVE-Li-Cycle Holdings, Priority Technology, 3M
U.S. STOCKS ON THE MOVE-Madrigal Pharmaceuticals, Coinbase, Fractyl
BioXcel Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
BioXcel Therapeutics rises on narrower Q4 loss
Brief: BioXcel Therapeutics Q4 Basic EPS USD -0.76
BioXcel Therapeutics Inc expected to post a loss of 91 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Bicycle Therapeutics, Molson Coors, LianBio
Brief: Bioxcel Therapeutics Announces Termination Of Proposed Public Offering
BioXcel Therapeutics rises after co scraps stock offering
U.S. STOCKS ON THE MOVE-Perpetua Resources, Nvidia, SiriusXM
U.S. STOCKS ON THE MOVE-Lowe's, Bit Digital Snap
U.S. STOCKS ON THE MOVE-Diamondback, Rivian Automotive, BioXcel Therapeutics
BioXcel rises on FDA's 'fast track' tag for prostate cancer therapy